Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of EUR 57.83 million. The enterprise value is 104.98 million.

Market Cap	57.83M
Enterprise Value	104.98M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.06M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	35.59
PS Ratio	0.59
PB Ratio	0.73
P/TBV Ratio	0.87
P/FCF Ratio	31.38
P/OCF Ratio	13.63
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.52, with an EV/FCF ratio of 56.96.

EV / Earnings	-8.11
EV / Sales	1.07
EV / EBITDA	18.52
EV / EBIT	n/a
EV / FCF	56.96

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.66.

Current Ratio	1.86
Quick Ratio	0.74
Debt / Equity	0.66
Debt / EBITDA	9.25
Debt / FCF	28.50
Interest Coverage	0.14

Financial Efficiency

Return on equity (ROE) is -14.69% and return on invested capital (ROIC) is 0.13%.

Return on Equity (ROE)	-14.69%
Return on Assets (ROA)	0.11%
Return on Invested Capital (ROIC)	0.13%
Return on Capital Employed (ROCE)	0.24%
Revenue Per Employee	181,122
Profits Per Employee	-23,985
Employee Count	590
Asset Turnover	0.61
Inventory Turnover	1.15

Taxes

In the past 12 months, Dr. Hönle AG has paid 879,000 in taxes.

Income Tax	879,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.83% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-50.83%
50-Day Moving Average	9.57
200-Day Moving Average	9.45
Relative Strength Index (RSI)	42.04
Average Volume (20 Days)	2,069

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of EUR 97.81 million and -12.95 million in losses. Loss per share was -2.14.

Revenue	97.81M
Gross Profit	60.24M
Operating Income	287,000
Pretax Income	-11.82M
Net Income	-12.95M
EBITDA	4.67M
EBIT	287,000
Loss Per Share	-2.14

Full Income Statement

Balance Sheet

The company has 5.51 million in cash and 52.52 million in debt, giving a net cash position of -47.02 million.

Cash & Cash Equivalents	5.51M
Total Debt	52.52M
Net Cash	-47.02M
Net Cash Per Share	n/a
Equity (Book Value)	79.42M
Book Value Per Share	13.08
Working Capital	26.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.24 million and capital expenditures -2.40 million, giving a free cash flow of 1.84 million.

Operating Cash Flow	4.24M
Capital Expenditures	-2.40M
Free Cash Flow	1.84M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.59%, with operating and profit margins of 0.29% and -13.24%.

Gross Margin	61.59%
Operating Margin	0.29%
Pretax Margin	-12.09%
Profit Margin	-13.24%
EBITDA Margin	4.77%
EBIT Margin	0.29%
FCF Margin	1.88%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-22.40%
FCF Yield	3.19%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.78 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	6